Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERAVACYCLINE vs ERDAFITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERAVACYCLINE vs ERDAFITINIB: Safety Overview

Metric ERAVACYCLINE ERDAFITINIB
Total FAERS Reports 144 1,106
Deaths Reported 16 315
Death Rate 11.1% 28.5%
Hospitalizations 33 226
Average Patient Age 54.8 yrs 66.6 yrs
% Female Patients 34.7% 37.9%
FDA Approval Date Aug 27, 2018 Apr 12, 2019
Manufacturer Tetraphase Pharmaceuticals, Inc. Janssen Products LP
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription